Drug
Epacadostat
Epacadostat: highest development phase Phase 2, developed by Incyte. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| Epacadostat NCT03414229 | Phase 2 | Sarcoma |
| Epacadostat NCT03516708 | Phase 1/2 | Rectal Cancer |
Latest
No recent events.
Follow Epacadostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.